The research on whether cannabis can provide short-term relief of ADHD symptoms is mixed, and researchers are still trying to learn more about cannabis and its potential effects on individuals with ADHD. While some studies suggest that cannabis may help manage certain symptoms such as hyperactivity and impulsivity, others warn of potential risks and long-term consequences. As the debate continues, many individuals with ADHD are turning to cannabis for relief.
Marijuana is linked to relaxation, there has been a growing interest in how it might benefit certain ADHD traits like restlessness and impulsivity. Some individuals report feeling more focused and calm after using cannabis, while others experience heightened anxiety and decreased cognitive function. It is essential for individuals considering cannabis as a treatment for ADHD to weigh the potential benefit against the possible risks.
The finding that 73% of patients with both ADHD and cannabis use were prescribed stimulant medications necessitates enhanced training and education for healthcare providers. It is crucial for medical professionals to understand the potential interactions between cannabis and ADHD medications to provide safe and effective treatment options for patients. More research is needed to determine the best course of action for individuals with co-occurring ADHD and cannabis use.
Conclusions. Our results suggest that ADHD shares a larger number of concordant influencing variants with CUD than with CU and that ADHD–CUD comorbidity may have a unique genetic basis. Understanding the genetic factors that contribute to both ADHD and cannabis use disorder can help inform personalized treatment strategies for individuals with co-occurring conditions.
Weed and ADHD both impact sleep in adolescents in surprising ways. Neurotypical teens may face elevated risk for problematic cannabis use if they have ADHD, highlighting the importance of early intervention and support for at-risk individuals. Parents, educators, and healthcare providers play a crucial role in identifying and addressing sleep disturbances in adolescents with ADHD and cannabis use.
A new study reveals nuanced findings on the neuropsychiatric risks of prenatal cannabis exposure. The research found a slight increase in the likelihood of ADHD symptoms in children exposed to cannabis in utero, underscoring the importance of avoiding cannabis use during pregnancy. Healthcare providers should educate pregnant individuals about the potential risks of cannabis use on fetal development.
The Department of Health and Social Care (DHSC) told the BBC while there were no cannabis-based medicines licensed for the treatment of ADHD on the market, ongoing research is exploring the potential therapeutic benefit of cannabis for individuals with ADHD. It is essential for policymakers and healthcare professionals to stay informed about the latest developments in cannabis research to provide evidence-based care for individuals with ADHD.
A meta-analysis found that 27% of individuals with ADHD develop cannabis use disorder during their lives, with 19% affected at the time of the study. The high prevalence of cannabis use disorder among individuals with ADHD highlights the need for targeted interventions and support services for this vulnerable population. Healthcare providers should screen individuals with ADHD for substance use disorders and provide appropriate treatment referrals as needed.
A British dad has opened up on his experience after being prescribed medicinal cannabis to help him cope with his ADHD. He shared how cannabis has improved his focus, mood, and overall quality of life, highlighting the potential benefit of medical cannabis for individuals with ADHD. While more research is needed to fully understand the effects of cannabis on ADHD, personal stories like his shed light on the real-world impact of cannabis as a treatment option.
